In some tumors, such as melanoma, gastric cancer, osteosarcoma, prostate cancer, nonsmall cell lung cancer, nasopharyngeal carcinoma, and pancreatic cancer, Wnt5a is overexpressed and plays the role of an oncogene [20–24]. This evidence concerns the gene WNT5A and Familial prostate cancer.